Frank E. Thomas, See Remarks at Orchard Therapeutics plc (ORTX), bought 10,000 shares at $0.75 ($8K) on 2022-04-01, disclosed to the SEC on 2022-04-04.
Open-market purchase of $8k ORTX by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| AMAG | SELL | 2015-08-07 | $1.0M | — | Filing → |
| AMAG | SELL | 2015-06-08 | $1.4M | — | Filing → |
| AMAG | SELL | 2013-01-04 | $156K | — | Filing → |